AbbVie, Shire enter detailed talks on combination

The Associated PressJuly 14, 2014 

Drugmakers AbbVie and Shire are in detailed talks about a possible combination after AbbVie once again raised the deal price and gave Shire shareholders a bigger stake in the new company.

Shire says North Chicago, Illinois-based AbbVie is now offering a cash-stock combination valued at 53.20 British pounds ($91.10) for each share of Shire, which is headquartered on the British island of Jersey.

The new offer totals roughly $53.68 billion and represents an increase from AbbVie's previous proposal, which amounted to around $51.3 billion pounds.

Shire Plc shareholders also would own about 25 percent of the combined new company, up from the 24 percent stake proposed in the most recent offer.

Shire had rejected three unsolicited offers from AbbVie Inc. before asking for a revised proposal earlier this month.

Lexington Herald-Leader is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere in the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. Thank you for taking the time to offer your thoughts.

Commenting FAQs | Terms of Service